Medical protheses containing a gel-filler comprising principally water and cellulose derivative

• US 5,531,786 A
• Filed: 01/28/1994
• Issued: 07/02/1996
• Est. Priority Date: 04/13/1992
• Status: Expired due to Fees

• Current Assignee: Allergan, Inc. (Canada) (Abbvie Incorporated)
• Original Assignee: Larry C. Perry, Maxwell G. Patrick
• Inventors: Maxwell, G. Patrick, Perry, Larry C.
• Primary Examiner(s): Milano, Michael J.
• Application Number:
  US08/188,107
• Time in Patent Office: 886 Days
• Field of Search: 623/8, 623/11, 424/422, 424/423
• US Class Current: 623/8
• CPC Class Codes: A61F 2/12 Mammary prostheses and implants
• CPC Class Codes: A61F 2/26 Penis implants
• CPC Class Codes: A61L 27/20 Polysaccharides
• CPC Class Codes: A61L 27/52 Hydrogels or hydrocolloids
• CPC Class Codes: C08L 1/28 Alkyl ethers
• CPC Class Codes: C08L 83/04 Polysiloxanes

Abstract

This invention relates to a medical prosthesis containing a gel filler material comprising principally a cellulose derivative in water. The gel filler in the prosthesis may further contain a lubricating agent. The invention also relates to a method of augmenting or reconstructing a human breast comprising the steps of subcutaneously implanting a medical prosthesis with the gel filler material into a human body. In another aspect, the invention relates to a method of preparing medical protheses comprising the steps of filling an outer envelope of a medical-grade elastomer with the gel filler material and sealing the envelope to form a medical prosthesis. The components of the gel are preferably biocompatible so as not adversely to affect human beings. The materials used to make the gel filler are non-toxic. The prostheses of the present invention have similar characteristics to the human breast. These protheses may be used for breast augmentation or reconstruction.

Claims

1. A sealed implantable prosthesis for implantation into soft tissue for replacing or augmenting the tissues, comprising an outer envelope forming a hollow sealed shell defining an enclosed volume, the hollow shell being made from a biocompatible medical-grade elastomer suitable for implantation into a human body and being filled with a gel filler with a predetermined density to provide a feel simulating the characteristic of the corresponding tissue part, wherein the gel filler of said predetermined density is obtained from a colloidal mixture of water and a cellulose derivative selected from the group consisting of an alkylcellulose, a hydroxyalkylcellulose, a hydroxyalkyl alkylcellulose, a metal carboxyalkylcellulose, a metal carboxyalkyl hydroxyalkylcellulose, a cross-linked cellulose derivative, and mixtures of two or more thereof, provided that the gel filler is free of polyethyleneoxide, wherein the gel filler is retained in the sealed shell to maintain constant its determined density.

2. The implantable prosthesis of claim 1 wherein the cellulose derivative is selected from the group consisting of hydroxyethyl methylcellulose;

hydroxypropyl methylcellulose;

potassium, lithium, magnesium or calcium carboxymethylcellulose;

potassium, lithium, or magnesium carboxymethyl, hydroxyethylcellulose;

or mixtures of two or more thereof.

3. The implantable prosthesis of claim 1 wherein the cellulose derivative is selected from the group consisting of methylcellulose and hydroxyethylcellulose.

4. The implantable prosthesis of claim 1 wherein the envelope is a medical-grade silicon.

5. The implantable prosthesis of claim 1 further comprising a lubricating agent.

6. The implantable prosthesis according to claim 1, wherein the water is present in the gel filler in an amount greater than about 70% by weight of the gel filler.

7. The implantable prosthesis according to claim 6, wherein the water is present in an amount from about 75% to about 95% by weight of the gel filler.

8. The implantable prosthesis according to claim 6, wherein the cellulose derivative is present in an amount of about 0.5% to about 15% by weight of the gel filler.

9. The implantable prosthesis according to claim 1, wherein the water is present in the gel filler in a major amount so that the volume of the gel filler is determined substantially by the volume of the water.

10. The implantable prosthesis according to claim 1, wherein the gel filler consists essentially of a mixture of water and the cellulose derivative.

11. The implantable prosthesis according to claim 6, wherein the cellulose derivative is present in an amount from about 0.5% to about 8% by weight of gel filler.

12. The implantable prosthesis according to claim 1, wherein the gel filler has a density from about 0.8 to about 1.5 g/cm₃.

19. A method of augmenting or reconstructing a human breast, comprising the step of subcutaneously implanting the sealed medical prosthesis of claim 1 into a human being.

13. A sealed implantable prosthesis for implantation into soft tissue for replacing or augmenting the tissues, comprising an outer envelope forming a hollow sealed shell defining an enclosed volume, the hollow shell being made from a biocompatible medical-grade elastomer suitable for implantation into a human body and being filled with a gel filler with a predetermined density to provide a feel simulating the characteristic of the corresponding tissue part, wherein the gel filler of said predetermined density is obtained from a colloidal mixture of water and a cellulose derivative selected from the group consisting of hydroxyethyl methylcellulose;

hydroxypropyl methylcellulose;

potassium, lithium, magnesium or calcium carboxymethylcellulose;

potassium, lithium, or magnesium carboxymethyl hydroxyethylcellulose; and

mixtures of two or more thereof, provided that the gel filler is free of polyethyleneoxide, wherein the gel filler is retained in the sealed shell to maintain constant its determined density.

14. The implantable prosthesis of claim 13 wherein the envelope is a medical-grade silicone.

15. A sealed implantable prosthesis according to claim 13, wherein the cellulose derivative in said gel filler includes a cross-linked cellulose derivative.

16. A sealed implantable prosthesis for implantation into soft tissue for replacing or augmenting the tissues, comprising an outer envelope forming a hollow sealed shell defining an enclosed volume, the hollow shell being made from a biocompatible medical-grade elastomer suitable for implantation into a human body and being filled with a gel filler with a predetermined density to provide a feel simulating the characteristic of the corresponding tissue part, wherein the gel filler of said predetermined density is obtained from a colloidal mixture of water and an alkylcellulose or a hydroxyalkyl alkylcellulose, and mixtures thereof, provided that the gel filler is free of polyethyleneoxide, wherein the gel filler is retained in the sealed shell to maintain constant its determined density.

17. The implantable prosthesis of claim 16 wherein the alkyl cellulose is methylcellulose.

18. The implantable prosthesis of claim 16 wherein the hydroxyalkylcellulose is hydroxyethylcellulose.

20. A sealed implantable prosthesis for implantation into soft tissue for replacing or augmenting the tissues, comprising an outer envelope forming a hollow sealed shell defining an enclosed volume, the hollow shell being made from a biocompatible medical-grade elastomer suitable for implantation into a human body and being filled with a gel filler with a predetermined density to provide a feel simulating the characteristic of the corresponding tissue part, wherein the gel filler of said predetermined density is obtained from a colloidal mixture of water and a cellulose derivative selected from the group consisting of an alkylcellulose, a hydroxyalkylcellulose, a hydroxyalkyl alkylcellulose, a metal carboxyalkylcellulose, a metal carboxyalkyl hydroxyalkylcellulose and mixtures of two or more thereof, provided that the gel filler is free of polyethyleneoxide, wherein the gel filler is retained in the sealed shell to maintain constant its determined density.

21. A sealed implantable prosthesis according to claim 20, wherein the cellulose derivative in said gel filler includes a cross-linked cellulose derivative.

22. A sealed implantable prosthesis for implantation into soft tissue for replacing or augmenting the tissues, comprising an outer envelope forming a hollow sealed shell defining an enclosed volume, the hollow shell being made from a biocompatible medical-grade elastomer suitable for implantation into a human body and being filled with a gel filler with a predetermined density to provide a feel simulating the characteristic of the corresponding tissue part, wherein the gel filler of said predetermined density is obtained from a colloidal mixture of water and a biocompatible cellulose derivative, a cross-linked cellulose derivative, and mixtures of two or more thereof, said biocompatible cellulose, respectively, cross-linked cellulose derivative(s) being capable of producing said biocompatible gel of predetermined density by the amount thereof admixed to water present in the mixture in a major amount, provided that the gel filler is free of polyethyleneoxide, wherein the gel filler is retained in the sealed shell to maintain constant its predetermined density.